Your session is about to expire
← Back to Search
Study Summary
This trial is testing a new treatment called elinzanetant for hot flashes, which are intense feelings of heat, sweating, and redness of the skin. The treatment works by blocking a substance
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Which specific group of individuals is the most suitable to participate in this study?
"For potential inclusion in this clinical trial, patients should experience hot flashes and fall within the age range of 40 to 65 years. The study is currently accepting approximately 60 eligible participants."
Is the recruitment phase for this medical study currently ongoing?
"According to the latest information on clinicaltrials.gov, this trial is presently accepting participants. The initial posting was made on January 8th, 2024, and the most recent update occurred on January 12th, 2024."
What is the current number of individuals under observation in this medical research study?
"Indeed, as per the information provided on clinicaltrials.gov, this trial is presently in the process of recruiting eligible individuals. The initial posting date for this study was January 8th, 2024 and it was last updated on January 12th, 2024. A total of 60 participants are being sought from a single designated site."
What is the level of safety associated with the treatment sequence A-C-D-B for individuals?
"Based on the classification of this trial as a Phase 1 study, our team assigns a safety rating of 1 to the treatment sequences A-C-D-B. This indicates that there is limited data available regarding both safety and efficacy."
Is the age criterion for participant inclusion in this study limited to individuals above 60 years old?
"Subjects who meet the age criteria for this trial must be above 40 years old and below 65 years of age."
Share this study with friends
Copy Link
Messenger